News and events
- All
- Events
- Press releases
- Publications
All
- All
- Events
- Press releases
- Publications
Bio International Convention – June 5-8, 2023 – Boston, USA
Our CEO and COO are attending this partnering event in person to explore opportunities to collaborate in delivering new medicines to prevent and treat infectious ...
June 3, 2023
Read More
Antibody Engineering & Therapeutics Europe 2023 – June 6-8, 2023 – Amsterdam, The Netherlands
Our Head of Preclinical Development is attending this event in person to meet the antibody community.
June 3, 2023
Read More
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
Currently circulating SARS-CoV-2 variants have gained complete or significant resistance to all SARSCoV-2-neutralizing antibodies that have been used in the clinic. Such antibodies can prevent ...
March 27, 2023
Read More
Bio€quity Europe— May 12-14, 2023 – Dublin, Ireland
Excited to be a part of the Presenting Company Class of 2023 at BioEquity: Europe 2023!
March 27, 2023
Read More
ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19
ExeVir Bio and VIB-UGent’s bioRxiv pre-print reports on S2-binding camelid single-domain antibody-based drug, XVR013, that targets the Achilles’ heel in the SARS-CoV-2 viral spike Focus ...
March 13, 2023
Read More